AstraZeneca Pharmaceutical – A Road to Death

AstraZeneca is a globally recognized pharmaceutical and biopharmaceutical company based in Cambridge, England, with its registered office in London. Established in 1999, AstraZeneca pharmaceutical resulted from the merger between Sweden’s Astra AB, which originated in 1913, and the UK’s Zeneca Group PLC, initially part of Imperial Chemical Industries’ agrochemicals division.

AstraZeneca pharmaceutical lineup boasts some jaw-dropping treatments: Tagrisso, a powerful weapon against lung cancer; Lynparza, tackling ovarian and breast cancers; Symbicort, a crucial aid for those battling asthma and COPD; and Farxiga, a game changer for managing type 2 diabetes and the AstraZeneca COVID-19 vaccine.